Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

The purpose of this study is to determine whether an exercise program comprised of strength and endurance training will lower fasting insulin levels in a group of breast cancer survivors. Insulin may be involved in the risk of breast cancer recurrence.

Key facts

Study ID

NCT00153894

Run by

Dana-Farber Cancer Institute

People needed

100

Starts

2003-12-01

Expected to finish

2008-02-01

Last updated by the study team

2016-06-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• History of pathologically confirmed stage I-IIIa invasive breast cancer
• Adjuvant chemotherapy and/or radiation must be completed at least 3 months prior to enrollment
• Body mass index > 25 and/or a body composition analysis of >30

You may not qualify if…

• Patients taking herceptin
• Evidence of residual or distant disease
• Use of any medication expected to affect insulin levels
• Baseline exercise of more than 20 minutes two times per week
• Active malignancy
• Diabetes mellitus
• Heart disease or uncontrolled hypertension
• Presence of any condition that might be expected to impact a participant's ability to perform physical activity

Where it is running

• Dana Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.